Publicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (23)

2024

  1. Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia

    Genes and Immunity, Vol. 25, Núm. 1, pp. 43-54

  2. Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations

    Clinica Chimica Acta, Vol. 552

2023

  1. Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases

    Pathology Research and Practice, Vol. 247

2022

  1. Analysis of Bone Histomorphometry in Rat and Guinea Pig Animal Models Subject to Hypoxia

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  2. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  3. Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

2021

  1. Differential Ca2+ responses and store operated Ca2+ entry in primary cells from human brain tumors

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1868, Núm. 8

2020

  1. A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus

    Molecular Pharmaceutics, Vol. 17, Núm. 5, pp. 1608-1620

  2. A comprehensive custom panel evaluation for routine hereditary cancer testing: Improving the yield of germline mutation detection

    Journal of Translational Medicine, Vol. 18, Núm. 1

  3. Bone regeneration with autologous adipose-derived mesenchymal stem cells: A reliable experimental model in rats

    MethodsX, Vol. 7

  4. Germline genetic findings which may impact therapeutic decisions in families with a presumed predisposition for hereditary breast and ovarian cancer

    Cancers, Vol. 12, Núm. 8, pp. 1-17

2019

  1. A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer

    Breast, Vol. 43, pp. 91-96

  2. Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer

    Molecular Carcinogenesis, Vol. 58, Núm. 1, pp. 156-160

2018

  1. Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants

    Breast Cancer Research and Treatment, Vol. 171, Núm. 1, pp. 53-63

  2. Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients

    Infection and Immunity, Vol. 86, Núm. 12

  3. Repair of maxillary cystic bone defects with mesenchymal stem cells seeded on a cross-linked serum scaffold

    Journal of Cranio-Maxillofacial Surgery, Vol. 46, Núm. 2, pp. 222-229

2017

  1. Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?

    European Journal of Neurology, Vol. 24, Núm. 9, pp. 1108-1115

2016

  1. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells

    Biochemical Pharmacology, Vol. 102, pp. 78-96

2015

  1. Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: Myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer

    Laboratory Medicine, Vol. 46, Núm. 2, pp. 123-135

2014

  1. The unfolded protein response and the phosphorylations of activating transcription factor 2 in the trans-activation of il23a promoter produced by β-glucans

    Journal of Biological Chemistry, Vol. 289, Núm. 33, pp. 22942-22957